|
STIP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.752000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.067600E-02 |
| Normal-vs-Stage2 |
8.340600E-01 |
| Normal-vs-Stage3 |
4.150500E-02 |
| Normal-vs-Stage4 |
6.372400E-02 |
| Stage1-vs-Stage2 |
3.332800E-01 |
| Stage1-vs-Stage3 |
6.175800E-03 |
| Stage1-vs-Stage4 |
2.646100E-02 |
| Stage2-vs-Stage3 |
6.030500E-02 |
| Stage2-vs-Stage4 |
2.651600E-02 |
| Stage3-vs-Stage4 |
5.473800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.089400E-01 |
| Normal-vs-AfricanAmerican |
6.823000E-01 |
| Normal-vs-Asian |
1.763030E-01 |
| Caucasian-vs-AfricanAmerican |
7.365400E-01 |
| Caucasian-vs-Asian |
8.796200E-02 |
| AfricanAmerican-vs-Asian |
7.698200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.797750E-01 |
| Normal-vs-Female |
1.228500E-02 |
| Male-vs-Female |
4.784900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.870200E-01 |
| Normal-vs-Extreme_Weight |
1.333240E-01 |
| Normal-vs-Obese |
6.582800E-01 |
| Normal-vs-Extreme_Obese |
1.258110E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.325200E-01 |
| Normal_Weight-vs-Obese |
7.517400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.791400E-01 |
| Extreme_Weight-vs-Obese |
1.274960E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.295400E-01 |
| Obese-vs-Extreme_Obese |
1.189600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.000500E-02 |
| Normal-vs-Age(41-60Yrs) |
8.412200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.938000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.485000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.295700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.082120E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.241200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.261600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.881800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.963240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.550000E-02 |
| Normal-VS-Type2 PRCC |
8.386200E-01 |
| Normal-VS-KIRP CIMP |
1.85695000000097E-05 |
| Normal-VS-Unclassified PRCC |
5.205000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.698950E-01 |
| Type1 PRCC-VS-KIRP CIMP |
<1E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
3.146300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.08030251411151E-11 |
| Type2 PRCC-VS-Unclassified PRCC |
4.959800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.4967995166113E-10 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.188000E-01 |
| Normal-vs-N1 |
1.806270E-04 |
| Normal-vs-N2 |
7.182200E-01 |
| N0-vs-N1 |
4.27560000000327E-05 |
| N0-vs-N2 |
6.088600E-01 |
| N1-vs-N2 |
2.626800E-01 |
|
|
